| Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant … T Petit, M Wilt, M Velten, R Millon, JF Rodier, C Borel, R Mors, P Haegele, ... European journal of cancer 40 (2), 205-211, 2004 | 398 | 2004 |
| Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases JL Lagrange, A Ramaioli, MC Chateau, C Marchal, M Resbeut, P Richaud, ... Radiology 216 (1), 197-205, 2000 | 240 | 2000 |
| Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study A Italiano, I Di Mauro, J Rapp, G Pierron, N Auger, L Alberti, F Chibon, ... The Lancet Oncology 17 (4), 532-538, 2016 | 181 | 2016 |
| Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network G De Pinieux, M Karanian, F Le Loarer, S Le Guellec, S Chabaud, ... PLoS One 16 (2), e0246958, 2021 | 157 | 2021 |
| Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single … JM Coindre, I Hostein, G Maire, J Derré, L Guillou, A Leroux, JP Ghnassia, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 154 | 2004 |
| Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting T Petit, C Borel, JP Ghnassia, JF Rodier, A Escande, R Mors, P Haegelé Clinical Cancer Research 7 (6), 1577-1581, 2001 | 144 | 2001 |
| A quantitative study of normal nephrogenesis in the human fetus: its implication in the natural history of kidney changes due to low obstructive uropathies B Gasser, Y Mauss, JP Ghnassia, R Favre, M Kohler, O Yu, JL Vonesch Fetal diagnosis and therapy 8 (6), 371-384, 1993 | 78 | 1993 |
| Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. JF Rodier, JC Janser, T Routiot, E David, G Ott, O Schneegans, ... Oncology reports 6 (6), 1249-1301, 1999 | 70 | 1999 |
| High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study M Lacroix-Triki, S Mathoulin-Pelissier, JP Ghnassia, G Macgrogan, ... European Journal of Cancer 42 (17), 2946-2953, 2006 | 53 | 2006 |
| Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort T Grinda, N Joyon, A Lusque, S Lefèvre, L Arnould, F Penault-Llorca, ... NPJ breast cancer 7 (1), 41, 2021 | 44 | 2021 |
| Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance R Millon, D Muller, I Schultz, R Salvi, JP Ghnassia, T Frebourg, B Wasylyk, ... Oral oncology 37 (8), 620-631, 2001 | 44 | 2001 |
| 2014 update of the GEFPICS'recommendations for HER2 status determination in breast cancers in France F Penault-Llorca, A Vincent-Salomon, G MacGrogan, P Roger, I Treilleux, ... Annales de pathologie 34 (5), 352-365, 2014 | 39* | 2014 |
| Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy … T Petit, M Wilt, M Velten, JF Rodier, JP Fricker, P Dufour, JP Ghnassia Breast cancer research and treatment 124 (2), 387-391, 2010 | 33 | 2010 |
| Are BRCA1 mutations a predictive factor for anthracycline-based neoadjuvant chemotherapy response in triple-negative breast cancers? T Petit, M Wilt, J Rodier, D Muller, J Ghnassia, P Dufour, J Fricker Journal of Clinical Oncology 25 (18_suppl), 580-580, 2007 | 30 | 2007 |
| Lymphatic mapping and sentinel node biopsy of operable breast cancer JF Rodier, T Routiot, H Mignotte, JC Janser, A Bremond, E David, ... World journal of surgery 24 (10), 1220-1226, 2000 | 26 | 2000 |
| Update of the GEFPICS'recommendations for HER2 status determination in breast cancers in France F Penault-Llorca, A Vincent-Salomon, JP Bellocq, MC Matthieu, ... Annales de pathologie 30 (5), 357-373, 2010 | 25 | 2010 |
| 2021 update of the GEFPICS'recommendations for HER2 status assessment in invasive breast cancer in France C Franchet, L Djerroudi, A Maran-Gonzalez, O Abramovici, M Antoine, ... Annales de Pathologie 41 (6), 507-520, 2021 | 19 | 2021 |
| Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification N Weingertner, N Meyer, AC Voegeli, D Guenot, S Renaud, G Massard, ... Pathology 47 (4), 320-328, 2015 | 19 | 2015 |
| Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study D Bruyere, F Monnien, P Colpart, P Roncarati, L Vuitton, E Hendrick, ... Modern Pathology 34 (1), 116-130, 2021 | 18 | 2021 |
| Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes H Bonnefoi, G MacGrogan, C Poncet, R Iggo, F Pommeret, T Grellety, ... British journal of cancer 120 (9), 913-921, 2019 | 13 | 2019 |
